Federal Register / Vol. 87, No. 35 / Tuesday, February 22, 2022 / Notices 9631 

Dated: February 15, 2022. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–03667 Filed 2–18–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Eye Institute; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Eye Institute 

Special Emphasis Panel; NEI Secondary Data 

Analysis Applications (R21). 

Date: March 28, 2022. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Eye Institute, National 

Institutes of Health, 6700B Rockledge Drive, 

Suite 3400, Bethesda, MD 20892 (Virtual 

Meeting). 

Contact Person: Ashley Fortress, Ph.D., 

Designated Federal Official, Division of 

Extramural Activities, National Eye Institute, 

National Institutes of Health, 6700B 

Rockledge Drive, Ste. 3400, Bethesda, MD 

20892, (301) 451–2020, ashley.fortress@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.867, Vision Research, 

National Institutes of Health, HHS) 

Dated: February 15, 2022. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–03668 Filed 2–18–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Minority Health 

and Health Disparities; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Minority Health and Health Disparities 

Special Emphasis Panel; HIV Health 

Disparity Research in Primary Care Settings. 

Date: March 30, 2022. 

Time: 2:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Gateway Plaza, 7201 Wisconsin Ave., 

Bethesda, MD 20817 (Virtual Meeting). 

Contact Person: Xinli Nan, M.D., Ph.D., 

Scientific Review Officer, Division of 

Scientific Programs, National Institute on 

Minority Health and Health Disparities, 

National Institutes of Health, Gateway 

Building, 7201 Wisconsin Avenue, Bethesda, 

MD 20892, 301–594–7784, Xinli.Nan@

nih.gov. 

Dated: February 16, 2022. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–03665 Filed 2–18–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; URGenT: Translational 

Efforts to Advance Gene-based Therapies for 

Ultra-Rare Neurological and Neuromuscular 

Disorders. 

Date: March 9, 2022. 

Time: 10:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Mirela Milescu, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Activities, 

NINDS/NIH NSC, 6001 Executive Boulevard, 

Suite 3208, MSC 9529, Bethesda, MD 20892, 

mirela.milescu@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: February 15, 2022. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–03666 Filed 2–18–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Notice of Meeting 

Pursuant to Public Law 92–463, 

notice is hereby given that the 

Substance Abuse and Mental Health 

Services Administration’s (SAMHSA) 

Center for Substance Abuse Prevention 

(CSAP) Drug Testing Advisory Board 

(DTAB) will convene via web 

conference on March 9, 2022, from 

10:00 a.m. ET to 1:00 p.m. ET. 

The board will meet in open-session 

on March 9, 2022, from 10:00 a.m. ET 

to 1:00 p.m. ET, to discuss the 

Mandatory Guidelines for Federal 

Workplace Drug Testing Programs with 

updates from the Department of 

Transportation, the Nuclear Regulatory 

Commission and the Food and Drug 


lotter on DSK11XQN23PROD with NOTICES1
9632 Federal Register / Vol. 87, No. 35 / Tuesday, February 22, 2022 / Notices 

1The statute confers this authority on the head of 

each Federal agency. The Secretary of DHS’s 

authority is delegated to the Coast Guard and other 

DHS organizational elements by DHS Delegation 

No. 0160.1, para. II.B.34. 

Administration. Other discussion topics 

include a presentation on the Drug-Free 

Workplace Program Summit meeting 

scheduled for May, 2022, NLCP drug 

testing results, and synthetic urines and 

adulteration. 

Meeting registration information can 

be completed at http://snacregister.

samhsa.gov/MeetingList.aspx. Web 

conference and call information will be 

sent after completing registration. 

Meeting information and a roster of 

DTAB members may be obtained by 

accessing the SAMHSA Advisory 

Committees website, https://

www.samhsa.gov/about-us/advisorycouncils/meetings or by contacting the 

Designated Federal Officer, Lisa S. 

Davis, M.S. 

Committee Name: Substance Abuse 

and Mental Health Services 

Administration, Center for Substance 

Abuse Prevention, Drug Testing 

Advisory Board. 

Dates/Time/Type: March 9, 2022, 

from 10:00 a.m. to 1:00 p.m.: OPEN. 

Place: Substance Abuse and Mental 

Health Services Administration, 5600 

Fishers Lane, Rockville, MD 20857. 

Contact: Lisa S. Davis, M.S., Social 

Science Analyst, Center for Substance 

Abuse Prevention, 5600 Fishers Lane, 

Rockville, Maryland 20857, Telephone: 

(240) 276–1440, Email: Lisa.Davis@

samhsa.hhs.gov. 

Anastasia Marie Donovan, 

Public Health Advisor, Division of Workplace 

Programs. 

[FR Doc. 2022–03616 Filed 2–18–22; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2022–0105] 

Cooperative Research and 

Development Agreement—Evaluation 

of Teledyne FLIR SF280HDEP 

AGENCY: Coast Guard, DHS. 

ACTION: Notice of intent; request for 

comments. 

SUMMARY: The Coast Guard announces 

its intent to enter into a cooperative 

research and development agreement 

(CRADA) to evaluate and potentially 

modify target classification technology 

used in conjunction with electrooptical/infra-red (E.O./IR) systems. The 

Coast Guard is currently considering 

partnering with Teledyne FLIR, Inc. and 

solicits public comment on the possible 

participation of other parties in the 

proposed CRADA, and the nature of that 

participation. The Coast Guard also 

invites other potential non-Federal 

participants, who have the interest and 

capability to bring similar contributions 

to this type of research, to consider 

submitting proposals for consideration 

in similar CRADAs. 

DATES: Comments must reach the Coast 

Guard on or before March 24, 2022. 

Synopses of proposals regarding future 

CRADAs must also reach the Coast 

Guard on or before March 24, 2022 

ADDRESSES: Submit comments online at 

http://www.regulations.gov following 

website instructions. Submit synopses 

of proposals regarding future CRADAs 

to Mr. Jay Carey at his address listed in 

the FOR FURTHER INFORMATION CONTACT

section. 

FOR FURTHER INFORMATION CONTACT: If 

you have questions on this notice or 

wish to submit proposals for future 

CRADAs, contact Mr. Jay Carey, Project 

Official, Aviation Branch, U.S. Coast 

Guard Research and Development 

Center, 1 Chelsea Street, New London, 

CT 06320, telephone 860–271–2600, 

email RDC-info@uscg.mil. 

SUPPLEMENTARY INFORMATION: 

Public Participation and Request for 

Comments 

We request public comments on this 

notice. Although we do not plan to 

publish responses to comments in the 

Federal Register, we will respond 

directly to commenters and may modify 

our proposal in light of comments. 

Comments should be marked with 

docket number USCG–2022–0105 and 

should provide a reason for each 

suggestion or recommendation. You 

should provide personal contact 

information so that we can contact you 

if we have questions regarding your 

comments; but please note that all 

comments will be posted to the online 

docket without change and that any 

personal information you include can be 

searchable online. For more about 

privacy and the docket, visit http://

www.regulations.gov/privacyNotice. We 

do accept anonymous comments. 

We encourage you to submit 

comments through the Federal Portal at 

http://www.regulations.gov. If your 

material cannot be submitted using 

http://www.regulations.gov, contact the 

Coast Guard (see FOR FURTHER

INFORMATION CONTACT). Documents 

mentioned in this notice and all public 

comments, will be in our online docket 

at http://www.regulations.gov and can 

be viewed by following that website’s 

instructions. Additionally, if you go to 

the online docket and sign up for email 

alerts, you will be notified when 

comments are posted. 

Do not submit detailed proposals for 

future CRADAs to http://

www.regulations.gov. Instead, submit 

them directly to the Coast Guard (see 

FOR FURTHER INFORMATION CONTACT). 

Discussion 

CRADAs are authorized under 15 

U.S.C. 3710(a).1 A CRADA promotes the 

transfer of technology to the private 

sector for commercial use, as well as 

specified research or development 

efforts that are consistent with the 

mission of the Federal parties to the 

CRADA. The Federal party or parties 

agree with one or more non-Federal 

parties to share research resources, but 

the Federal party does not contribute 

funding. 

CRADAs are not procurement 

contracts. Care is taken to ensure that 

CRADAs are not used to circumvent the 

contracting process. CRADAs have a 

specific purpose and should not be 

confused with procurement contracts, 

grants, and other type of agreements. 

Under the proposed CRADA, the 

Coast Guard’s Research and 

Development Center (R&DC) will 

collaborate with one or more nonFederal participants. Together, the 

R&DC and the non-Federal participants 

will identify the capabilities, benefits, 

risks, and technical limitations of 

enhancing the SF280HD–EP to operate 

in support of USCG missions. 

We anticipate that the Coast Guard’s 

contributions under the proposed 

CRADA will include the following: 

(1) In conjunction with the nonFederal participant(s), assist in 

developing the evaluation test plan to be 

executed under the CRADA; 

(2) Provide the small unmanned 

aircraft system (SUAS) test range, test 

range support, facilities, and all 

approvals required for SUAS operation 

under the CRADA; 

(3) Provide airborne targets, operators, 

and associated equipment necessary to 

conduct the evaluation test plan; 

(4) Coordinate and receive any 

Unmanned Flight Clearance (UFC) for 

the evaluations to be executed under 

this CRADA, as required, to include: 

Privacy Threshold Analysis, Privacy 

Impact Assessment, Spectrum Approval 

with the Office of Information 

Assurance and Spectrum Policy (CG– 

65), the Federal Communications 

Commission (FCC), the National 

Telecommunications and Information 

Administration (NTIA) Local Range 


lotter on DSK11XQN23PROD with NOTICES1